Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul:191:1-8.
doi: 10.1016/j.thromres.2020.03.024. Epub 2020 Apr 21.

Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study

Thure Filskov Overvad  1 , Søren Due Andersen  2 , Torben Bjerregaard Larsen  3 , Gregory Y H Lip  4 , Mette Søgaard  3 , Flemming Skjøth  5 , Peter Brønnum Nielsen  3
Affiliations

Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study

Thure Filskov Overvad et al. Thromb Res. 2020 Jul.

Abstract

Background: Intracerebral hemorrhage is a devastating vascular event. Clinical factors prognostic of recurrence facilitating individualized post-bleeding patient management are sparsely described. We aimed to describe incidence of recurrence of intracerebral hemorrhage and explore the prognostic value of 25 clinical characteristics in patients with and without atrial fibrillation.

Methods: Cohort study of patients with incident intracerebral hemorrhage diagnosed from 2003 to 2016 identified using nationwide Danish administrative registries. Results reported as cumulative incidence of intracerebral recurrence accounting for competing risk of death. Univariate and multivariate prognostic factors for recurrence estimated using Cox regression (hazard ratios [HRs], 95% confidence intervals [CI]).

Results: We identified 9255 patients with incident intracerebral hemorrhage (median age 73 years, 46.6% females, 16% with atrial fibrillation). Five-year risks of recurrence of intracerebral hemorrhage were approximately 10% in the study population, although slightly higher for patients without atrial fibrillation. Prognostic factors for recurrence were broadly similar for patients with and without atrial fibrillation. Age in categories <60 years (reference), age 60-70 years (HR 1.29, 95% CI 1.02-1.64), age 70-80 years (HR 1.59, 95% CI 1.26-2.00), age >80 years (HR 1.19, 95% CI 0.91-1.55), nursing home residency (HR 1.48, 95% CI 1.02-2.13), and Scandinavian Stroke Scale score ('mild' versus 'moderate' (HR 1.40, 95% CI 1.13-1.72) and 'severe' (HR 1.96, 95% CI 1.61-2.39)) were the strongest prognostic factors.

Conclusion: Risk of recurrence of intracerebral hemorrhage after five years was approximately 10%. Clinical characteristics associated with recurrence were few and broadly similar for patients with and without atrial fibrillation, with age and measure of incident bleeding severity, as reflected by Scandinavian Stroke Scale score, being the most important.

Keywords: Atrial fibrillation; Intracerebral hemorrhage; Prognosis; Recurrence; Risk stratification; Stroke prevention.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Dr. Lip has received consulting fees from Bayer/Janssen, BMS/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife and Daiichi-Sankyo. Speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche, and Daiichi-Sankyo. Dr. Larsen has served as an investigator for Janssen Scientific Affairs, LLC, and Boehringer Ingelheim and received speaking fees from Bayer, BMS/Pfizer, Boehringer Ingelheim, MSD, and AstraZeneca. Mr. Nielsen has received speaking fees from Boehringer Ingelheim and Bayer, consulting fees from Bayer and Daiichi-Sankyo; and grant support from BMS/Pfizer. Mr. Skjøth has received consulting fees from Bayer. Ms. Søgaard, Dr. Overvad and Dr. Andersen report no disclosures.

Publication types

LinkOut - more resources